Personal care and cosmetic product manufacturers should take note that legislation on reforming FDA's OTC drug monograph program with a user fee program might regain momentum, says regulatory consultant David Steinberg.
Steinberg, president of Plainsboro, N.J.-based Steinberg & Associates Inc., a consultancy specializing in the OTC drug and personal care industries,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?